# Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings

> **NCT03343925** · — · COMPLETED · sponsor: **Kirby Institute** · enrollment: 140 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03343925
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-17
- **Primary completion:** 2021-07-01
- **Final completion:** 2022-04-11
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2022-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03343925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03343925, "Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03343925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*